Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Toxic Epidermal Necrolysis Associated With Allopurinol Administration

Toxic Epidermal Necrolysis Associated With Allopurinol Administration Abstract Allopurinol, now established as a standard form of therapy in hyperuricemia and gout, may be associated with life-threatening skin reactions. This study reports the occurrence of toxic epidermal necrolysis (TEN) in three patients receiving allopurinol. The patients had complicated medical illnesses and were receiving various other medications, but the most apparent common denominator was allopurinol ingestion. Two other cases of TEN and five cases of severe hypersensitivity reactions with vasculitis and extensive skin manifestations, secondary to this drug, have been described in the recent literature. Allopurinol has several unique biochemical and metabolic properties that may increase its ability to cause hypersensitivity or toxic skin reactions. References 1. Rundles RW, Wyngaarden JB, Hitchings GH, et al: Drugs and uric acid . Annu Rev Pharmacol 9:345-362, 1969.Crossref 2. Wyngaarden JB, Kelley WN: Disorders of purine and pyrimidine metabolism , in Stanbury JB, Wyngaarden JB, Fredrickson DS (eds): The Metabolic Basis of Inherited Disease , ed 3. New York, McGraw-Hill Book Co Inc, 1972, pp 946-948. 3. Vesell ES, Passananti T, Greene FE: Impairment of drug metabolism in man by allopurinol and nortriptyline . N Engl J Med 283:1484-1488, 1970.Crossref 4. Vesell ES, Passananti T, Greene FE, et al: Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man . Ann NY Acad Sci 179:752-773, 1971.Crossref 5. Kelley WN, Beardmore TD: Allopurinol: Alteration in pyrimidine metabolism in man . Science 169:388-390, 1970.Crossref 6. Beardmore TD, Cashman JS, Kelley WN: Mechanism of allopurinol mediated increase in enzyme activity in man . J Clin Invest 51:1823-1832, 1972.Crossref 7. Becking GC, Johnson WJ: The inhibition of tryptophan pyrrolase by allopurinol, an inhibitor of xanthine oxidase . Can J Biochem 45:1667-1672, 1967.Crossref 8. Kantor GL: Toxic epidermal necrolysis, azotemia and death after allopurinol therapy . JAMA 212:478-479, 1970.Crossref 9. Stratigos JB, Bartsokas SK, Capetanakis J: Further experiences of toxic epidermal necrolysis incriminating allopurinol, pyrazolone and derivatives . Br J Dermatol 86:564-567, 1972.Crossref 10. Mills RM Jr: Severe hypersensitivity reactions associated with allopurinol . JAMA 216:799-802, 1971.Crossref 11. Taub SJ: Severe hypersensitivity reactions associated with allopurinol . EENT Mon 50:268-269, 1971. 12. Jarzobski J, Ferry J, Wombolt D, et al: Vasculitis with allopurinol therapy . Am Heart J 79:116-121, 1970.Crossref 13. Young JL, Boswell RB, Nies AS: Severe allopurinol hypersensitivity . Arch Intern Med 134:553-558, 1974.Crossref 14. Stabenow DL: Toxic epidermal necrolysis . Postgrad Med 52:89-92, 1972. 15. Koblenzer PJ: Acute epidermal necrolysis . Arch Dermatol 95:608-617, 1967.Crossref 16. Lyell A: Toxic epidermal necrolysis: An eruption resembling scalding of the skin . Br J Dermatol 68:355-361, 1956.Crossref 17. Arbuthnott JP, Kent J, Lyell A, et al: Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus . Br J Dermatol 85:145-149, 1971.Crossref 18. Lyell A: A review of toxic epidermal necrolysis in Britain . Br J Dermatol 79:662-671, 1967.Crossref 19. Björnberg A: Fifteen cases of toxic epidermal necrolysis . Acta Dermatovener 53:149-152, 1973. 20. Stein KM, Schlappner OL, Heaton CL, et al: Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis . Br J Dermatol 86:46-52, 1972.Crossref 21. Rothenberg GR, Renna FS, Drew TM, et al: Staphylococcal scalded skin syndrome in an adult . Arch Dermatol 108:408-410, 1973.Crossref 22. Levine G, Norden CW: Staphylococcal scalded-skin syndrome in adults . N Engl J Med 287:1339-1340, 1972.Crossref 23. Norden CW, Mendelow H: Staphylococcal scalded-skin syndrome in adults . N Engl J Med 290:577, 1974. 24. Stüttgen G: Toxic epidermal necrolysis provoked by barbiturates . Br J Dermatol 88:291-293, 1973.Crossref 25. Strom J: Toxic epidermal necrolysis . Scand J Infect Dis 1:209-216, 1969. 26. Hunter JA, Davison AM: Toxic epidermal necrolysis associated with pentazocine therapy and severe reversible renal failure . Br J Dermatol 88:287-289, 1973.Crossref 27. Bailey G, Rosenbaum JM, Anderson B: Toxic epidermal necrolysis . JAMA 191:979-982, 1965.Crossref 28. Excess of ampicillin rashes associated with allopurinol or hyperuricemia, Boston Collaborative Drug Surveillance Program . N Engl J Med 286:505-507, 1972.Crossref 29. Allopurinol and cytotoxic drugs, Boston Collaborative Drug Surveillance Program . JAMA 227:1036-1040, 1974.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Toxic Epidermal Necrolysis Associated With Allopurinol Administration

Loading next page...
 
/lp/american-medical-association/toxic-epidermal-necrolysis-associated-with-allopurinol-administration-dkMg8E0kHU
Publisher
American Medical Association
Copyright
Copyright © 1975 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1975.01630200046002
Publisher site
See Article on Publisher Site

Abstract

Abstract Allopurinol, now established as a standard form of therapy in hyperuricemia and gout, may be associated with life-threatening skin reactions. This study reports the occurrence of toxic epidermal necrolysis (TEN) in three patients receiving allopurinol. The patients had complicated medical illnesses and were receiving various other medications, but the most apparent common denominator was allopurinol ingestion. Two other cases of TEN and five cases of severe hypersensitivity reactions with vasculitis and extensive skin manifestations, secondary to this drug, have been described in the recent literature. Allopurinol has several unique biochemical and metabolic properties that may increase its ability to cause hypersensitivity or toxic skin reactions. References 1. Rundles RW, Wyngaarden JB, Hitchings GH, et al: Drugs and uric acid . Annu Rev Pharmacol 9:345-362, 1969.Crossref 2. Wyngaarden JB, Kelley WN: Disorders of purine and pyrimidine metabolism , in Stanbury JB, Wyngaarden JB, Fredrickson DS (eds): The Metabolic Basis of Inherited Disease , ed 3. New York, McGraw-Hill Book Co Inc, 1972, pp 946-948. 3. Vesell ES, Passananti T, Greene FE: Impairment of drug metabolism in man by allopurinol and nortriptyline . N Engl J Med 283:1484-1488, 1970.Crossref 4. Vesell ES, Passananti T, Greene FE, et al: Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man . Ann NY Acad Sci 179:752-773, 1971.Crossref 5. Kelley WN, Beardmore TD: Allopurinol: Alteration in pyrimidine metabolism in man . Science 169:388-390, 1970.Crossref 6. Beardmore TD, Cashman JS, Kelley WN: Mechanism of allopurinol mediated increase in enzyme activity in man . J Clin Invest 51:1823-1832, 1972.Crossref 7. Becking GC, Johnson WJ: The inhibition of tryptophan pyrrolase by allopurinol, an inhibitor of xanthine oxidase . Can J Biochem 45:1667-1672, 1967.Crossref 8. Kantor GL: Toxic epidermal necrolysis, azotemia and death after allopurinol therapy . JAMA 212:478-479, 1970.Crossref 9. Stratigos JB, Bartsokas SK, Capetanakis J: Further experiences of toxic epidermal necrolysis incriminating allopurinol, pyrazolone and derivatives . Br J Dermatol 86:564-567, 1972.Crossref 10. Mills RM Jr: Severe hypersensitivity reactions associated with allopurinol . JAMA 216:799-802, 1971.Crossref 11. Taub SJ: Severe hypersensitivity reactions associated with allopurinol . EENT Mon 50:268-269, 1971. 12. Jarzobski J, Ferry J, Wombolt D, et al: Vasculitis with allopurinol therapy . Am Heart J 79:116-121, 1970.Crossref 13. Young JL, Boswell RB, Nies AS: Severe allopurinol hypersensitivity . Arch Intern Med 134:553-558, 1974.Crossref 14. Stabenow DL: Toxic epidermal necrolysis . Postgrad Med 52:89-92, 1972. 15. Koblenzer PJ: Acute epidermal necrolysis . Arch Dermatol 95:608-617, 1967.Crossref 16. Lyell A: Toxic epidermal necrolysis: An eruption resembling scalding of the skin . Br J Dermatol 68:355-361, 1956.Crossref 17. Arbuthnott JP, Kent J, Lyell A, et al: Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus . Br J Dermatol 85:145-149, 1971.Crossref 18. Lyell A: A review of toxic epidermal necrolysis in Britain . Br J Dermatol 79:662-671, 1967.Crossref 19. Björnberg A: Fifteen cases of toxic epidermal necrolysis . Acta Dermatovener 53:149-152, 1973. 20. Stein KM, Schlappner OL, Heaton CL, et al: Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis . Br J Dermatol 86:46-52, 1972.Crossref 21. Rothenberg GR, Renna FS, Drew TM, et al: Staphylococcal scalded skin syndrome in an adult . Arch Dermatol 108:408-410, 1973.Crossref 22. Levine G, Norden CW: Staphylococcal scalded-skin syndrome in adults . N Engl J Med 287:1339-1340, 1972.Crossref 23. Norden CW, Mendelow H: Staphylococcal scalded-skin syndrome in adults . N Engl J Med 290:577, 1974. 24. Stüttgen G: Toxic epidermal necrolysis provoked by barbiturates . Br J Dermatol 88:291-293, 1973.Crossref 25. Strom J: Toxic epidermal necrolysis . Scand J Infect Dis 1:209-216, 1969. 26. Hunter JA, Davison AM: Toxic epidermal necrolysis associated with pentazocine therapy and severe reversible renal failure . Br J Dermatol 88:287-289, 1973.Crossref 27. Bailey G, Rosenbaum JM, Anderson B: Toxic epidermal necrolysis . JAMA 191:979-982, 1965.Crossref 28. Excess of ampicillin rashes associated with allopurinol or hyperuricemia, Boston Collaborative Drug Surveillance Program . N Engl J Med 286:505-507, 1972.Crossref 29. Allopurinol and cytotoxic drugs, Boston Collaborative Drug Surveillance Program . JAMA 227:1036-1040, 1974.Crossref

Journal

Archives of DermatologyAmerican Medical Association

Published: Aug 1, 1975

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month